IMRA News and Press, IMARA Inc. From 09/06/20

Just one SPAC is scheduled for the week ahead. More SPACs may join the IPO calendar, and another wave of new filings will likely hit after Labor Day as well. Several companies are set to launch in the shortened holiday week, including software providers Unity Software (U), Snowflake (SNOW), ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead The tech sector will be in focus again in the week ahead as investors gauge if short-term pandemic p...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

BOSTON, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the Company w...

The European Commission has designated Imara's (NASDAQ: IMRA )  IMR-687 as Orphan drug for sickle cell disease. More news on: IMARA Inc., Healthcare stocks news, Read more ...

BOSTON, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the European C...

Gainers:  Comstock Mining (NYSEMKT: LODE ) +128% . More news on: Comstock Mining Inc., RISE Education Cayman Ltd, IMARA Inc., Stocks on the move, , Read more ...

TG Therapeutics reports development for Umbralisib TG Therapeutics Inc. ( TGTX ) reported that the FDA has accepted its New Drug Application for umbralisib. The drug candidate will be reviewed under the Priority Review pathway. It had been granted Breakthrough Therapy tag for treating ma...

IMARA Inc. (IMRA) Q2 2020 Results Earnings Conference Call August 14, 2020, 08:30 AM ET Company Participants Rahul Ballal - Chief Executive Officer Michael Gray - Chief Financial and Chief Operating Officer Conference Call Participants Yigal Nochomovitz - Citi Group Joseph ...

Imara (NASDAQ: IMRA ) : Q2 GAAP EPS of -$0.59 misses by $0.04 . More news on: IMARA Inc., Earnings news and commentary, Healthcare stocks news, Read more ...